Abstract
Various mechanisms, including high levels of cytokines and nitric oxide (NO), have been proposed as mediators for inflammation-induced cytochrome 450 down-regulation. However, the contribution of each of these mediators to the observed effects is controversial. We used an isolated perfused rat liver (IPRL) model to test the direct effects of NO donors on CYP450 down-regulation in the absence of cytokines or other confounding in vivo factors. Our hypothesis was that NO rapidly and concentration-dependently decreases CYP450 activities in IPRL. Livers were perfused (60 min) with 50 to 500 μM sodium nitroprusside (SNP) or 100 to 500 μM isosorbide dinitrate (ISDN) as NO donors, and the perfusate and biliary disposition of SNP, ISDN, and generated nitrate/nitrite (NOx) were determined. Additionally, at the end of perfusion, catalytic activities and protein levels of various cytochrome isoenzymes were measured. Both SNP and ISDN exhibited linear hepatic disposition with extraction ratios of ∼0.30 and 0.50, respectively. Furthermore, although in small amounts, both NO donors and NOx were found in the bile. Except for CYP2D1, the catalytic activities of all the studied isoenzymes were substantially (up to 85%) decreased by both NO donors. However, the apoprotein levels of isoenzymes remained largely unchanged. Additionally, the inhibitory effects of NO donors were concentration-dependent, with the concentrations of SNP producing one-half of maximum inhibition being in the order of 2C11 > 2B1/2 > 2E1 = 3A2 > 1A1/2. These studies indicate that the effects of NO on the down-regulation of cytochrome 450 catalytic activity are rapid, concentration-dependent, and isoenzyme-selective.
Footnotes
-
DOI: 10.1124/jpet.104.065557.
-
ABBREVIATIONS: P450, cytochrome P450; NO, nitric oxide; iNOS, inducible nitric-oxide synthase; LPS, lipopolysaccharide; AG, aminoguanidine; SNP, sodium nitroprusside; ISDN, isosorbide dinitrate; IPRL, isolated perfused rat liver; NOx, nitrate/nitrite; HPLC, high-performance liquid chromatography; E, hepatic extraction ratio; CLh, hepatic clearance; CLint, intrinsic clearance; CLbile, biliary clearance; ELISA, enzyme-linked immunosorbent assay; γ, steepness factor; ANOVA, analysis of variance; AUC, area under the curve.
- Received January 18, 2004.
- Accepted March 26, 2004.
- The American Society for Pharmacology and Experimental Therapeutics
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|